Please check your internet connection and try again.
# Potassium Chloride
## Overview
Potassium chloride (KCL) is an electrolyte that is essential for nerve and muscle function, particularly for the heart. It is available in oral and intravenous (IV) formulations.
## Primary Indications
* Treatment and prevention of hypokalemia.
## Adult Dosing
* **Oral:**
* **Prevention:** 20 mEq (10 mmol) per day in 1-2 divided doses.
* **Treatment:** 40-100 mEq (20-50 mmol) per day in 2-4 divided doses. Maximum dose generally not to exceed 20 mEq (10 mmol) per dose to minimize GI irritation. Extended-release formulations are often preferred for GI tolerance.
* **Intravenous (IV):**
* **Mild hypokalemia (serum K+ 3.0-3.5 mEq/L):** 10-20 mEq (5-10 mmol) added to 1 liter of IV fluid, infused over 1-2 hours.
* **Moderate hypokalemia (serum K+ 2.5-2.9 mEq/L):** 20-40 mEq (10-20 mmol) added to 1 liter of IV fluid, infused over 2-4 hours.
* **Severe hypokalemia (serum K+ < 2.5 mEq/L):** Requires careful titration based on serum potassium levels, ECG findings, and patient's clinical status. Generally, administer no more than 10-20 mEq (5-10 mmol) per hour. Higher rates (up to 40 mEq/hour) may be used in life-threatening situations but must be administered via a central venous catheter with continuous cardiac monitoring.
* **Maximum daily IV dose:** Not well-defined, but typically does not exceed 200 mEq (100 mmol) in 24 hours, depending on severity and monitoring.
## Pediatric Dosing
* **Oral:** 1-2 mEq/kg/day (0.5-1 mmol/kg/day) divided into 1-4 doses. Maximum daily dose generally 20-40 mEq (10-20 mmol).
* **Intravenous (IV):** 0.5-1 mEq/kg/dose (0.25-0.5 mmol/kg/dose) added to IV fluids, infused over 1-3 hours. Maximum concentration typically 40 mEq/L (20 mmol/L) in peripheral lines and 80 mEq/L (40 mmol/L) in central lines. Higher concentrations may be used in critical care with central access and continuous monitoring. Dosing should be guided by serum potassium levels and clinical status.
## Dose Adjustments
* **Renal Impairment:** Use with extreme caution. Potassium is renally excreted, and impaired renal function significantly increases the risk of hyperkalemia. Dose reduction or avoidance may be necessary. Monitor potassium levels closely.
## Contraindications
* Hyperkalemia (serum K+ > 5.0 mEq/L).
* Conditions that predispose to hyperkalemia, such as severe renal impairment, Addison's disease, untreated Addison's disease, acute dehydration, severe burns, or extensive tissue injury.
* Concurrent use of potassium-sparing diuretics or ACE inhibitors in patients with compromised renal function may necessitate extreme caution.
## Adverse Effects
* **Common:** Nausea, vomiting, abdominal pain, diarrhea (oral). Phlebitis, pain at injection site (IV).
* **Serious:** Hyperkalemia (manifesting as muscle weakness, fatigue, paresthesias, arrhythmias, cardiac arrest). Peptic ulceration, GI bleeding or perforation (especially with rapid-release oral formulations).
## Key Drug Interactions
* **ACE inhibitors, ARBs, Potassium-sparing diuretics (e.g., spironolactone, amiloride), NSAIDs, Trimethoprim:** Increased risk of hyperkalemia.
* **Digitalis glycosides:** Hypokalemia can increase the risk of digitalis toxicity. Conversely, hyperkalemia can reduce the efficacy of digitalis.
* **Neuromuscular blocking agents:** Potassium levels can affect neuromuscular transmission.
## Monitoring
* Serum potassium levels (frequency depends on severity of hypokalemia, route of administration, and renal function).
* ECG for signs of hyperkalemia (peaked T waves, widened QRS complex, loss of P waves) especially with IV administration or in patients with renal impairment.
* Renal function (BUN, creatinine).
* Signs and symptoms of hypokalemia (muscle cramps, weakness, fatigue, arrhythmias) and hyperkalemia (numbness, tingling, weakness, slow pulse, faintness).
## Clinical Pearls
* Oral potassium chloride should be taken with meals or immediately after to minimize gastric irritation.
* IV potassium chloride must be diluted appropriately and administered slowly to prevent cardiac arrhythmias and vein irritation. Never administer as an IV push or bolus.
* Concentrated IV potassium solutions should only be administered via a central venous catheter.
* Consider the total daily potassium intake from all sources, including IV fluids and other medications.
* In patients with diabetic ketoacidosis, serum potassium may appear normal or elevated initially but will drop rapidly as insulin therapy is initiated, requiring aggressive potassium replacement.
**Please verify current prescribing information for the most up-to-date recommendations.**
